Gadolinium toxicity: Iron and ferroportin as central targets.
about
Deep gray matter iron measurement in patients with liver cirrhosis using quantitative susceptibility mapping: Relationship with pallidal T1 hyperintensity.Synthesis and functionalization of NaGdF4:Yb,Er@NaGdF4 core-shell nanoparticles for possible application as multimodal contrast agents.Changes in Signal Intensity of the Dentate Nucleus and Globus Pallidus in Pediatric Patients: Impact of Brain Irradiation and Presence of Primary Brain Tumors Independent of Linear Gadolinium-based Contrast Agent Administration.Does radiation therapy increase gadolinium accumulation in the brain?: Quantitative analysis of T1 shortening using R1 relaxometry in glioblastoma multiforme patients.Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents.
P2860
Gadolinium toxicity: Iron and ferroportin as central targets.
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Gadolinium toxicity: Iron and ferroportin as central targets.
@ast
Gadolinium toxicity: Iron and ferroportin as central targets.
@en
type
label
Gadolinium toxicity: Iron and ferroportin as central targets.
@ast
Gadolinium toxicity: Iron and ferroportin as central targets.
@en
prefLabel
Gadolinium toxicity: Iron and ferroportin as central targets.
@ast
Gadolinium toxicity: Iron and ferroportin as central targets.
@en
P1476
Gadolinium toxicity: Iron and ferroportin as central targets.
@en
P2093
Sundararaman Swaminathan
P304
P356
10.1016/J.MRI.2016.08.016
P577
2016-08-28T00:00:00Z